FORTICE II SUP ALIM 30 CPR PIERRE FABRE FARMA DE MEXICO SA DE CV Requiere monitoreo neuromuscular continuo

Description

Requiere monitoreo neuromuscular continuo

KADCYLA® 160 mg es un medicamento de uso intravenoso que contiene Trastuzumab Emtansina (T-DM1)

PRODUCTO DE ALTA ESPECIALIDAD

GLYCINE MAX

Fabricante o laboratorio: zydus

FORTICE II SUP ALIM 30 CPR PIERRE FABRE FARMA DE MEXICO SA DE CV Requiere monitoreo neuromuscular continuo

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy